TCL-737 A Global Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With EBV-Positive (EBV+) Relapsed/Refractory Peripheral T Cell Lymphomas (NAVAL-1)
| Autor: | Nair, Ranjit, Chang, Hung, Brian Greenwell, Irl, Hua Hsiao, Hui-Hua, Ayer, Swaminathan, Zinzani, Luigi, Strickland, Donald, González-Barca, Eva |
|---|---|
| Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S527-S527 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect